secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001493152-26-019788
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack publishes peer-reviewed study showing CBGM accuracy MARD 6.8% over 240 days in ovine model
--------------------------------------------------------------------------------

- Study in Journal of Diabetes Research shows weighted average MARD of 6.8% across 79 IV glucose tolerance tests in ovine model.
- 34 devices implanted in 17 sheep; no device-related adverse events observed over up to 240 days.
- Results support path to IDE submission with FDA for further clinical development toward commercialization.
- Prior first-in-human study demonstrated MARD of 7.7% with 99% data capture and no serious adverse events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315226019788/0001493152-26-019788-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315226019788/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-019788

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer